Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Completed · Phase 3

Conditions studied: Cerebral Arterial Diseases

In brief

The study will evaluate the efficacy and safety of Dotarem enhanced MRA in patients suffering from carotid or vertebral arterial disease.

Key facts

Study ID

NCT01012674

Run by

Guerbet

People needed

211

Starts

2009-10-01

Expected to finish

2010-12-01

Last updated by the study team

2016-06-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female, aged more than 18 years
• Strongly suspected of having carotid or vertebral arterial disease
• Scheduled (or to be scheduled) to undergo computed tomography angiography (CTA) examination

You may not qualify if…

• Known grade IV or V chronic kidney disease (GFR<30 mL/min/1.73m²)
• Contraindication to MRI
• Acute renal dysfunction within the 6 months preceding Dotarem®-enhanced MRA examination

Where it is running

• Guerbet LLC — Bloomington, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.